Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome
- 1 October 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 105 (10), 2228-2234
- https://doi.org/10.1038/ajg.2010.200
Abstract
OBJECTIVES: The Rome III classification system treats functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C) as distinct disorders, but this distinction appears artificial, and the same drugs are used to treat both. This study's hypothesis is that FC and IBS-C defined by Rome III are not distinct entities. METHODS: In all, 1,100 adults with a primary care visit for constipation and 1,700 age- and gender-matched controls from a health maintenance organization completed surveys 12 months apart; 66.2% returned the first questionnaire. Rome III criteria identified 231 with FC and 201 with IBS-C. The second survey was completed by 195 of the FC and 141 of the IBS-C cohorts. Both surveys assessed the severity of constipation and IBS, quality of life (QOL), and psychological distress. RESULTS: (i) Overlap: if the Rome III requirement that patients meeting criteria for IBS cannot be diagnosed with FC is suspended, 89.5% of IBS-C cases meet criteria for FC and 43.8% of FC patients fulfill criteria for IBS-C. (ii) No qualitative differences between FC and IBS-C: 44.8% of FC patients report abdominal pain, and paradoxically IBS-C patients have more constipation symptoms than FC. (iii) Switching between diagnoses: by 12 months, 1/3 of FC transition to IBS-C and 1/3 of IBS-C change to FC. CONCLUSIONS: Patients identified by Rome III criteria for FC and IBS-C are not distinct groups. Revisions to the Rome III criteria, possibly including incorporation of physiological tests of transit and pelvic floor function, are needed.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacologic treatment of constipation: what is new?Current Opinion in Pharmacology, 2008
- A Placebo-Controlled Trial of Prucalopride for Severe Chronic ConstipationNew England Journal of Medicine, 2008
- Natural History of Functional Gastrointestinal Disorders: A 12-year Longitudinal Population-Based StudyGastroenterology, 2007
- Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational StudyThe American Journal of Gastroenterology, 2005
- Overlap of gastrointestional symptom complexes in a US communityNeurogastroenterology & Motility, 2004
- AGA technical review on irritable bowel syndromeGastroenterology, 2002
- AGA technical review on constipationGastroenterology, 2000
- Psychometric Validation of a Constipation Symptom Assessment QuestionnaireScandinavian Journal of Gastroenterology, 1999
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- Evidence for the ambiguity of the term constipation: the role of irritable bowel syndrome.Gut, 1994